These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6134816)

  • 1. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
    van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the metabolism of hexobarbital and aminopyrine in vivo in rats.
    van der Graaff M; Vermeulen NP; Heij P; de Bree H; Breimer DD
    Xenobiotica; 1986 Dec; 16(12):1091-6. PubMed ID: 3798956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia.
    Vermeulen NP; Danhof M; Setiawan I; Breimer DD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):201-5. PubMed ID: 6864540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
    van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of N-methylcyclobarbital in vivo in rabbit and rat.
    Miyano K; Shimodouzono Y; Toki S
    Xenobiotica; 1985 May; 15(5):381-9. PubMed ID: 2863899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
    Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of hexobarbital enantiomers in the rat.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Drug Metab Dispos; 1983; 11(5):489-93. PubMed ID: 6138236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated rat hepatocytes and 9000 g rat liver supernatant as metabolic systems for the study of the pharmacokinetics of barbiturates.
    Yih TD; van Rossum JM
    Xenobiotica; 1977 Sep; 7(9):573-82. PubMed ID: 602254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of some homologous series of barbiturates in the intact rat and in the isolated perfused rat liver.
    Yih TD; van Rossum JM
    J Pharmacol Exp Ther; 1977 Oct; 203(1):184-92. PubMed ID: 909052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of zoxazolamine in the rat.
    Van der Graaff M; Vermeulen NP; Crul IE; Breimer DD
    Drug Metab Dispos; 1986; 14(3):331-5. PubMed ID: 2872034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic differences in the microsomal metabolism of the isomers of hexobarbital.
    McCarthy JS; Stitzel RE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):772-8. PubMed ID: 5111462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relationship between the phase of the sex cycle and differences in the rate of hexenal detoxication and its induction by phenobarbital in female rats].
    Rozanova VD
    Farmakol Toksikol; 1979; 42(1):29-33. PubMed ID: 570513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of apparent intrinsic clearances of simultaneously administered S (+) and d3R (-) hexobarbital in the rat.
    van der Graaff M; Vermeulen NP; Hofman PH; Breimer DD
    Biochem Pharmacol; 1987 Apr; 36(8):1321-3. PubMed ID: 3593417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Zhou S; Kestell P; Tingle MD; Paxton JW
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.
    Breimer DD; de Boer AG
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):169-78. PubMed ID: 9299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between manganese and phenobarbital on hexobarbital hypnosis in the male rat.
    Deimling MJ; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):165-8. PubMed ID: 6622829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.